Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition-Reference-Cited by-同舟云学术

Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition

Published:2018-03-16 Issue: Volume: Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Report

Author:

Jin Hangbin¹,Zhao Yanyan²,Zhang Shirong²,Yang Jianfeng¹,Zhang Xiaofeng¹,Ma Shenglin²

Affiliation:

1. Department of Gastroenterology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China

2. Department of Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang 310006, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperthermia improves gemcitabine sensitivity of pancreatic cancer cells by suppressing the EFNA4/β-catenin axis and activating dCK;Heliyon;2024-04

2. LncRNAs as nodes for the cross-talk between autophagy and Wnt signaling in pancreatic cancer drug resistance;International Journal of Biological Sciences;2024

3. The future opportunities and remaining challenges in the application of nanoparticle‐mediated hyperthermia combined with chemo‐radiotherapy in cancer;WIREs Nanomedicine and Nanobiotechnology;2023-10

4. Targeted therapy and drug resistance in gastric and pancreatic cancer;Treatment Landscape of Targeted Therapies in Oncology;2023

5. Tongue squamous cell carcinoma resists hyperthermia treatment by promoting Id-1 expression mediated EMT;Bulletin du Cancer;2022-09